Howland Capital Management LLC Sells 962 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

Key Points

• Howland Capital Management LLC reduced its holdings in Thermo Fisher Scientific Inc. by 1.2%, selling 962 shares and retaining a total of 78,809 shares, valued at approximately $39.25 million.
• The company recently announced a quarterly dividend of $0.43 per share, with an ex-dividend date set for September 15th and a current dividend yield of 0.4%.
• Thermo Fisher reported a quarterly earnings per share (EPS) of $5.36, surpassing analysts' expectations by $0.14, alongside a revenue of $10.86 billion.

Howland Capital Management LLC cut its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 1.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 78,809 shares of the medical research company's stock after selling 962 shares during the quarter. Thermo Fisher Scientific accounts for 1.7% of Howland Capital Management LLC's portfolio, making the stock its 17th biggest holding. Howland Capital Management LLC's holdings in Thermo Fisher Scientific were worth $39,249,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Bernard Wealth Management Corp. bought a new position in Thermo Fisher Scientific in the fourth quarter worth $25,000. Ameriflex Group Inc. acquired a new position in shares of Thermo Fisher Scientific in the 4th quarter valued at $30,000. IMA Advisory Services Inc. bought a new position in shares of Thermo Fisher Scientific during the 1st quarter worth about $35,000. Navigoe LLC acquired a new stake in shares of Thermo Fisher Scientific during the 4th quarter valued at about $37,000. Finally, Smallwood Wealth Investment Management LLC acquired a new position in Thermo Fisher Scientific in the first quarter worth about $37,000. 89.23% of the stock is currently owned by institutional investors.

Insider Activity

In related news, EVP Gianluca Pettiti sold 400 shares of Thermo Fisher Scientific stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $479.98, for a total transaction of $191,992.00. Following the transaction, the executive vice president owned 22,367 shares of the company's stock, valued at $10,735,712.66. This trade represents a 1.76% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.33% of the company's stock.

Thermo Fisher Scientific Stock Down 2.0%

Shares of NYSE TMO opened at $467.56 on Friday. The company has a current ratio of 1.93, a quick ratio of 1.50 and a debt-to-equity ratio of 0.65. The firm has a market capitalization of $176.50 billion, a PE ratio of 27.04, a price-to-earnings-growth ratio of 2.55 and a beta of 0.77. The firm's 50-day moving average is $419.50 and its 200-day moving average is $468.31. Thermo Fisher Scientific Inc. has a 1 year low of $385.46 and a 1 year high of $627.88.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last released its earnings results on Wednesday, July 23rd. The medical research company reported $5.36 EPS for the quarter, topping analysts' consensus estimates of $5.22 by $0.14. The firm had revenue of $10.86 billion during the quarter, compared to analyst estimates of $10.68 billion. Thermo Fisher Scientific had a net margin of 15.24% and a return on equity of 16.82%. The business's quarterly revenue was up 2.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $5.37 EPS. Equities analysts expect that Thermo Fisher Scientific Inc. will post 23.28 EPS for the current year.

Thermo Fisher Scientific Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Monday, September 15th will be given a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Monday, September 15th. Thermo Fisher Scientific's payout ratio is presently 9.95%.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on TMO. HSBC reaffirmed a "hold" rating and set a $510.00 price objective on shares of Thermo Fisher Scientific in a report on Thursday, July 24th. Wells Fargo & Company cut their target price on Thermo Fisher Scientific from $570.00 to $565.00 and set an "overweight" rating for the company in a research report on Thursday, July 24th. Evercore ISI dropped their price objective on Thermo Fisher Scientific from $500.00 to $480.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Robert W. Baird boosted their target price on shares of Thermo Fisher Scientific from $553.00 to $567.00 and gave the company an "outperform" rating in a research note on Thursday, July 24th. Finally, Barclays increased their target price on shares of Thermo Fisher Scientific from $450.00 to $490.00 and gave the stock an "equal weight" rating in a research report on Thursday, July 24th. Six analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company's stock. According to MarketBeat.com, Thermo Fisher Scientific has a consensus rating of "Moderate Buy" and an average price target of $593.00.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.